COVID-19 Evidence Reviews
as of 10/22/21
menu
 
 

VA ESP Reviews
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
7/1/21
Veazie S, O'Neil M, LaFavor B, et al.  | VA Evidence Synthesis Program
Aim: To compare the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assess whether the prevalence of mental health disorders varies by patient and disease characteristics, and ascertain mental health care utilization and resource needs for adults following hospitalization for COVID-19.
UPDATED
VA ESP
MENTAL HEALTH
6/2/21
Wilt T, Kaka AS, MacDonald R, et al. | VA Evidence Synthesis Program
Aim: To assess the clinical effectiveness and harms of remdesivir in hospitalized adults with COVID-19.
UPDATED
VA ESP
4/27/21
Mackey K, Kansagara D, Vela K | Ann Intern Med
Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19.
UPDATED
WHO COLLABORATIVE
VA ESP
4/2/21
Ayers CK, Kondo KK, Williams BE, et al. | J Gen Intern Med
Aim: To understand disparities in H1N1 vaccine uptake by race/ethnicity, socioeconomic status (SES), rural/urban residence, population density, and disability status, and factors associated with unequal uptake, as well as the benefits and harms of interventions designed to attenuate inequities in H1N1 vaccine uptake
UPDATED
VA ESP
INFECTION CONTROL
1/15/21
Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program
Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer
UPDATED
VA ESP
8/18/20
Greer N, Wilt T, Duan-Porter D, et al  | VA Evidence Synthesis Program
VA ESP
7/10/20
Lewis J, Mackey K | VA Evidence Synthesis Program
Aim: To critically appraise the identified study and provide additional context for study findings.
VA ESP
6/26/20
Helfand M | VA Evidence Synthesis Program
Aim: To review the evidence for using corticosteroids to treat acute respiratory distress syndrome in patients with COVID-19.
VA ESP
6/26/20
Duan-Porter W | VA Evidence Synthesis Program
Aim: To explore the length of stay in the intensive care unit (ICU) and time on invasive mechanical ventilation for adult patients with COVID-19.
UPDATED
VA ESP
6/20/20
Maldonado E, Tao D, Mackey K | J Gen Intern Med
Aim: To synthesize evidence on thromboembolism incidence and outcomes with antithrombotic therapies in COVID-19.
UPDATED
VA ESP
CANDIDATE THERAPEUTICS
5/15/20
Lindquist I, Mackey K, Edwards S | VA Evidence Synthesis Program
Aim: To provide author feedback and critical appraisal in a similar manner as would be provided by editorial staff of a journal.
VA ESP